arrow
Return

Screening for hepatitis C in average and high-risk populations of Qatar using rapid point-of-care testing

delete2015-08-01
delete5
delete
OA
AI
M
Manik Sharma *
S
Saad Al Kaabi
A
Anil K John
N
N. Al Dweik
H
Hameed Ullah Wani
R
Ragesh Babu Thandassary
M
Moutaz Derbala
F
Fuad Pašić
M
Munnera Al Mohannadi
R
R. Yacoub
M
Mohd Tariq Butt
R
Rajvir Singh
DOI:10.1177/2050640615580725delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Background: Screening for hepatitis C has been found to be beneficial in high-risk individuals and baby boomers'. Objective: Our aim was to screen for hepatitis C in average and high-risk individuals and compare the disease characteristics and response to treatment among the screened group (SG) and non-screened group (NSG). Method: Community-based screening for hepatitis C was done in the average and high-risk populations of Qatar. Screening was done using rapid point-of-care testing. All patients with stage 1 fibrosis on liver biopsy were treated with pegylated interferon and ribavirin. Results: In total, 13,704 people were screened and 272 (2%, 95% CI (1.8-2.2%) had positive antibodies to hepatitis C. During the same period, 237 non-screened patients (NSG) with hepatitis C were referred for treatment. Alanine and aspartate aminotransferases (ALT, AST) and overall fibrosis were significantly lower in the SG as compared with the NSG (p=0.04, 0.04 and 0.01, respectively). The response to treatment was similar in the SG as compared with the NSG (sustained viral response 61.7 % versus 69.1%, p=0.55). Average-risk patients had significantly lower ALT levels (p=0.04) but had similar response to treatment as the high-risk individuals (sustained viral response 63.2 % versus 61%, p=0.87). Conclusion: Screening detects hepatitis C with lesser fibrosis but does not result in better response to pegylated interferon and ribavirin as compared with non-screened patients.
Keywords:
Screening
hepatitis C
fibrosis
treatment
Qatar
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

United European Gastroenterology Journal cover
United European Gastroenterology Journal
IF:
6.7
Papers:
1.9K
Citations:
4.9K

Organization

H
hamad medical corporation
Scholars:
4.8K
Papers: 2.6K
Citations: 2